Leukemia, Promyelocytic, Acute

Displaying 1 - 2 of 2CSV
de Botton, S., Cluzeau, T., Vigil, C., Cook, R. J., Rousselot, P., Rizzieri, D. A., Liesveld, J. L., Fenaux, P., Braun, T., Banos, A., Jurcic, J. G., Sekeres, M. A., Savona, M. R., Roboz, G. J., Bixby, D., Madigan, K., Volkert, A., Stephens, K., Kang-Fortner, Q., … Stein, E. M. (2023). Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML. Blood Advances, 7(9), 1858–1870. https://doi.org/10.1182/bloodadvances.2022008806
Publication Date
Laurie, K. L., Lee, P., Rademaker, A., Alonzo, T. A., Wang, Y., Powell, B. L., Wu, D., Larson, R., Kutny, M., Gregory, J., Hijiya, N., & Feusner, J. (2022). Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance? Pediatric Blood & Cancer, 69(6). Portico. https://doi.org/10.1002/pbc.29613
Publication Date